{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:37:08Z","timestamp":1771328228326,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Carlos III Institute of Health, Ministry of Science and Innovation","award":["ISCIII, AES PI20\/00250"],"award-info":[{"award-number":["ISCIII, AES PI20\/00250"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03392-6","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:26:17Z","timestamp":1764944777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uncovering mirnomes of patients with interstitial lung diseases and an underlying autoimmune process"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9894-5699","authenticated-orcid":false,"given":"Olga","family":"S\u00e1nchez-Pernaute","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Vadillo Font","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Asunci\u00f3n","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cebri\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"L\u00f3pez-Mu\u00f1iz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredeswinda I.","family":"Romero-Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilda","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosal\u00eda","family":"Laporta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Victoria","family":"del Pozo Abeij\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Ab\u00e1solo Alc\u00e1zar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"M\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Jes\u00fas","family":"Rodr\u00edguez Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"3392_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1057643","volume":"10","author":"FI Romero-Bueno","year":"2023","unstructured":"Romero-Bueno FI, Rodr\u00edguez-Nieto MJ, Palacios Miras C, Mart\u00ednez Estupi\u00f1\u00e1n L, Mart\u00ednez-Becerra MJ, Vegas S\u00e1nchez MC, et al. Fine-tuning characterization of patients with interstitial pneumonia and an underlying autoimmune disease in real-world practice: we get closer with nailfold videocapillaroscopy. Front Med Lausanne. 2023;10:1057643. https:\/\/doi.org\/10.3389\/fmed.2023.1057643.","journal-title":"Front Med Lausanne"},{"key":"3392_CR2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary Fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:e44\u201368. https:\/\/doi.org\/10.1164\/rccm.201807-1255ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"3392_CR3","doi-asserted-by":"publisher","first-page":"e1086","DOI":"10.1002\/cti2.1086","volume":"81","author":"A McLean-Tooke","year":"2019","unstructured":"McLean-Tooke A, Moore I, Lake F. Idiopathic and immune-related pulmonary fibrosis: diagnostic and therapeutic challenges. Clin Transl Immunol. 2019;81:e1086. https:\/\/doi.org\/10.1002\/cti2.1086.","journal-title":"Clin Transl Immunol"},{"key":"3392_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/annrheumdis-2020-217230","volume":"80","author":"P Spagnolo","year":"2021","unstructured":"Spagnolo P, Distler O, Ryerson CJ, Tzouvelekis A, Lee JS, Bonella F, et al. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs). Ann Rheum Dis. 2021;80:143\u201350. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217230.","journal-title":"Ann Rheum Dis"},{"key":"3392_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1322806","volume":"14","author":"FS Shaikh","year":"2024","unstructured":"Shaikh FS, Siegel RJ, Srivastava A, Fox DA, Ahmed S. Challenges and promise of targeting MiRNA in rheumatic diseases: a computational approach to identify MiRNA association with cell types, cytokines, and disease mechanisms. Front Immunol. 2024;14:1322806. https:\/\/doi.org\/10.3389\/fimmu.2023.1322806.","journal-title":"Front Immunol"},{"key":"3392_CR6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733\u201348. https:\/\/doi.org\/10.1164\/rccm.201308-1483ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"3392_CR7","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, Kreuter M, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers JL, Nicholson AG, Ryerson CJ, Strek ME, Troy LK, Wijsenbeek M, Mammen MJ, Hossain T, Bissell BD, Herman DD, Hon SM, Kheir F, Khor YH, Macrea M, Antoniou KM, Bouros D, Buendia-Roldan I, Caro F, Crestani B, Ho L, Morisset J, Olson AL, Podolanczuk A, Poletti V, Selman M, Ewing T, Jones S, Knight SL, Ghazipura M, Wilson KC. Idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205:e18. -e47.","journal-title":"Am J Respir Crit Care Med"},{"key":"3392_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02317-5","volume":"24","author":"MA Nieto","year":"2023","unstructured":"Nieto MA, Sanchez-Pernaute O, Vadillo C, Rodriguez-Nieto MJ, Romero-Bueno F, L\u00f3pez-Mu\u00f1iz B, et al. Functional respiratory impairment and related factors in patients with interstitial pneumonia with autoimmune features (IPAF): multicenter study from NEREA registry. Respir Res. 2023;24:19. https:\/\/doi.org\/10.1186\/s12931-023-02317-5.","journal-title":"Respir Res"},{"key":"3392_CR9","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN, REDCap Consortium. The REDCap consortium: Building an international community of software platform partners. J Biomed Inf. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inf"},{"key":"3392_CR10","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, M\u00e9nard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsk\u00fd J, Wolfe F, Hawker G. 2010 rheumatoid arthritis classification criteria: an American college of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569\u201381. https:\/\/doi.org\/10.1002\/art.27584.","journal-title":"Arthritis Rheum"},{"key":"3392_CR11","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, M\u00fcller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE. 2013 classification criteria for systemic sclerosis: an American college of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347. https:\/\/doi.org\/10.1002\/art.38098.","journal-title":"Arthritis Rheum"},{"key":"3392_CR12","doi-asserted-by":"publisher","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dank\u00f3 K, Dimachkie MM, Feldman BM, Garcia-De La Torre I, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O\u2019Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (UK and Ireland). International Myositis Classification Criteria Project Consortium, the Euromyositis Register, and. 2017 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Arthritis Rheumatol. 2017;69:2271-82. https:\/\/doi.org\/10.1002\/art.40320.","DOI":"10.1002\/art.40320"},{"issue":"1","key":"3392_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2016","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data\u2010driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2016;69(1):35\u201345. https:\/\/doi.org\/10.1002\/art.39859.","journal-title":"Arthritis Rheumatol"},{"key":"3392_CR14","doi-asserted-by":"publisher","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstr\u00f8m K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirj\u00e1k L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kum\u00e1novics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, R\u00faa-Figueroa Fern\u00e1ndez \u00cd, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, D\u00f6rner T, Johnson SR. 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71:1400-12.https:\/\/doi.org\/10.1002\/art.40930.","DOI":"10.1002\/art.40930"},{"key":"3392_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1590\/s1806-37132011000100015","volume":"37","author":"J Solomon","year":"2011","unstructured":"Solomon J, Swigris JJ, Brown KK. Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol. 2011;37:100\u20139. https:\/\/doi.org\/10.1590\/s1806-37132011000100015.","journal-title":"J Bras Pneumol"},{"key":"3392_CR16","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, Mosca M, Noth I, Richeldi L, Strek ME, Swigris JJ, Wells AU, West SG, Collard HR, Cottin V. ERS\/ATS task force on undifferentiated forms of CTD-ILD. An official European respiratory society\/American thoracic society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46:976\u201387. https:\/\/doi.org\/10.1183\/13993003.00150-2015.","journal-title":"Eur Respir J"},{"key":"3392_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","volume":"6","author":"DA Lynch","year":"2018","unstructured":"Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner society white paper. Lancet Respir Med. 2018;6:138\u201353. https:\/\/doi.org\/10.1016\/S2213-2600(17)30433-2.","journal-title":"Lancet Respir Med"},{"key":"3392_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"issue":"W1","key":"3392_CR19","doi-asserted-by":"publisher","first-page":"W154","DOI":"10.1093\/nar\/gkad431","volume":"51","author":"S Tastsoglou","year":"2023","unstructured":"Tastsoglou S, Skoufos G, Miliotis M, Karagkouni D, Koutsoukos I, Karavangeli A, Kardaras FS, Hatzigeorgiou AG. DIANA-miRPath v4.0: expanding target-based MiRNA functional analysis in cell-type and tissue contexts. Nucleic Acids Res. 2023;51(W1):W154\u20139. https:\/\/doi.org\/10.1093\/nar\/gkad431.","journal-title":"Nucleic Acids Res"},{"key":"3392_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005. https:\/\/doi.org\/10.7554\/eLife.05005.","journal-title":"Elife"},{"key":"3392_CR21","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/nar\/gkw116","volume":"44","author":"N Ludwig","year":"2016","unstructured":"Ludwig N, Leidinger P, Becker K, Backes C, Fehlmann T, Pallasch C, et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res. 2016;44:3865\u201377. https:\/\/doi.org\/10.1093\/nar\/gkw116.","journal-title":"Nucleic Acids Res"},{"key":"3392_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12031173","volume":"12","author":"LB Jehn","year":"2023","unstructured":"Jehn LB, Costabel U, Boerner E, W\u00e4lscher J, Theegarten D, Taube C, et al. Serum KL-6 as a biomarker of progression at any time in fibrotic interstitial lung disease. J Clin Med. 2023;12:1173. https:\/\/doi.org\/10.3390\/jcm12031173.","journal-title":"J Clin Med"},{"key":"3392_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106689","volume":"191","author":"S Watanabe","year":"2022","unstructured":"Watanabe S, Kase K, Saeki K, Ohkura N, Murata A, Waseda Y, et al. Kinetic changes in serum KL-6 levels predict disease progression in patients with systemic sclerosis-associated interstitial lung disease. Respir Med. 2022;191:106689. https:\/\/doi.org\/10.1016\/j.rmed.2021.106689.","journal-title":"Respir Med"},{"key":"3392_CR24","unstructured":"Romero Bueno F, Vegas S\u00e1nchez MC, Ab\u00e1solo Alc\u00e1zar L, Rodr\u00edguez Nieto MJ, Vadillo Font C, Nieto MA, Cebrian L, L\u00f3pez-Mu\u00f1iz B, Loarce-Martos J, Rigual JA, Godoy H, Laporta R, Llorente Cubas I, Bonilla G, G\u00f3mez-Carrera L, Garc\u00eda-Vicu\u00f1a R, Jauregu\u00edzar A, Morell Hita JL, Valenzuela C. S\u00e1nchez Pernaute O. Los Cambios En Los niveles de Krebs von Den lungen 6 predicen El deterioro funcional En Pacientes Con Enfermedades Del Tejido Conectivo y neumonitis intersticial. Reumatol Clin. 2025; 21 Suppl 2:607 ."},{"key":"3392_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2022.113302","volume":"233","author":"C Xu","year":"2022","unstructured":"Xu C, Hou L, Zhao J, Wang Y, Jiang F, Jiang Q, et al. Exosomal let-7i-5p from three-dimensional cultured human umbilical cord mesenchymal stem cells inhibits fibroblast activation in silicosis through targeting TGFBR1. Ecotoxicol Environ Saf. 2022;233:113302. https:\/\/doi.org\/10.1016\/j.ecoenv.2022.113302.","journal-title":"Ecotoxicol Environ Saf"},{"key":"3392_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-021-08073-4","volume":"22","author":"UE Perera","year":"2021","unstructured":"Perera UE, Derseh HB, Dewage SNV, Stent A, Wijayarathna R, Snibson KJ. Evaluation of MicroRNA expression in a sheep model for lung fibrosis. BMC Genomics. 2021;22:827. https:\/\/doi.org\/10.1186\/s12864-021-08073-4.","journal-title":"BMC Genomics"},{"key":"3392_CR27","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12177","volume":"24","author":"G Huang","year":"2021","unstructured":"Huang G, Zhang J, Qing G, Liu D, Wang X, Chen Y, et al. Downregulation of miR\u2013483\u20135p inhibits TGF\u2013\u03b21\u2013induced EMT by targeting RhoGDI1 in pulmonary fibrosis. Mol Med Rep. 2021;24:538. https:\/\/doi.org\/10.3892\/mmr.2021.12177.","journal-title":"Mol Med Rep"},{"key":"3392_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14651","volume":"75","author":"OO Abdelaleem","year":"2021","unstructured":"Abdelaleem OO, Fouad NA, Shaker OG, Ahmed TI, Abdelghaffar NK, Eid HM, et al. Serum miR-224, miR-760, miR-483-5p, miR-378 and miR-375 as potential novel biomarkers in rheumatoid arthritis. Int J Clin Pract. 2021;75:e14651. https:\/\/doi.org\/10.1111\/ijcp.14651.","journal-title":"Int J Clin Pract"},{"key":"3392_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jaut.2017.12.015","volume":"89","author":"E Chouri","year":"2018","unstructured":"Chouri E, Servaas NH, Bekker CPJ, Affandi AJ, Cossu M, Hillen MR, et al. Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis. J Autoimmun. 2018;89:162\u201370. https:\/\/doi.org\/10.1016\/j.jaut.2017.12.015.","journal-title":"J Autoimmun"},{"key":"3392_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05407-0","volume":"22","author":"V Talevi","year":"2024","unstructured":"Talevi V, Melas K, Pehlivan G, Imtiaz MA, Kr\u00fcger DM, Centeno TP, et al. Peripheral whole blood MicroRNA expression in relation to vascular function: a population-based study. J Transl Med. 2024;22:670. https:\/\/doi.org\/10.1186\/s12967-024-05407-0.","journal-title":"J Transl Med"},{"key":"3392_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.arbres.2020.03.006","volume":"57","author":"N Matamala","year":"2021","unstructured":"Matamala N, Lara B, G\u00f3mez-Mariano G, Mart\u00ednez S, V\u00e1zquez-Dom\u00ednguez I, Otero-Sobrino \u00c1, et al. MiR-320c regulates SERPINA1 expression and is induced in patients with pulmonary disease. Arch Bronconeumol. 2021;57:457\u201363. https:\/\/doi.org\/10.1016\/j.arbres.2020.03.006.","journal-title":"Arch Bronconeumol"},{"key":"3392_CR32","doi-asserted-by":"publisher","first-page":"35789","DOI":"10.18632\/oncotarget.8937","volume":"7","author":"R Vishnubalaji","year":"2016","unstructured":"Vishnubalaji R, Hamam R, Yue S, Al-Obeed O, Kassem M, Liu FF, et al. Microrna-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1. Oncotarget. 2016;7:35789\u2013802. https:\/\/doi.org\/10.18632\/oncotarget.8937.","journal-title":"Oncotarget"},{"key":"3392_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/cbf.3328","volume":"36","author":"N Yang","year":"2018","unstructured":"Yang N, Wu L, Zhao Y, Zou N, Liu C. Microrna-320 involves in the cardioprotective effect of insulin against myocardial ischemia by targeting survivin. Cell Biochem Funct. 2018;36:166\u201371. https:\/\/doi.org\/10.1002\/cbf.3328.","journal-title":"Cell Biochem Funct"},{"key":"3392_CR34","doi-asserted-by":"publisher","first-page":"H980","DOI":"10.1152\/ajpheart.00737.2014","volume":"308","author":"B Xu","year":"2015","unstructured":"Xu B, Luo Y, Liu Y, Li BY, Wang Y. Platelet-derived growth factor-BB enhances MSC-mediated cardioprotection via suppression of miR-320 expression. Am J Physiol Heart Circ Physiol. 2015;308:H980\u20139. https:\/\/doi.org\/10.1152\/ajpheart.00737.2014.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3392_CR35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1165\/rcmb.2020-0002OC","volume":"63","author":"T Kadota","year":"2020","unstructured":"Kadota T, Yoshioka Y, Fujita Y, Araya J, Minagawa S, Hara H, et al. Extracellular vesicles from fibroblasts induce epithelial-cell senescence in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2020;63:623\u201336. https:\/\/doi.org\/10.1165\/rcmb.2020-0002OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3392_CR36","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1096\/fj.12-219493","volume":"27","author":"S Yang","year":"2013","unstructured":"Yang S, Cui H, Xie N, Icyuz M, Banerjee S, Antony VB, et al. Mir-145 regulates myofibroblast differentiation and lung fibrosis. FASEB J. 2013;27:2382\u201391. https:\/\/doi.org\/10.1096\/fj.12-219493.","journal-title":"FASEB J"},{"key":"3392_CR37","doi-asserted-by":"publisher","first-page":"15052","DOI":"10.1074\/jbc.RA119.007404","volume":"294","author":"J Wu","year":"2019","unstructured":"Wu J, Huang Q, Li P, Wang Y, Zheng C, Lei X, et al. Microrna-145 promotes the epithelial-mesenchymal transition in peritoneal dialysis-associated fibrosis by suppressing fibroblast growth factor 10. J Biol Chem. 2019;294:15052\u201367. https:\/\/doi.org\/10.1074\/jbc.RA119.007404.","journal-title":"J Biol Chem"},{"key":"3392_CR38","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3892\/ijmm.2014.1712","volume":"33","author":"P Li","year":"2014","unstructured":"Li P, Li J, Chen T, Wang H, Chu H, Chang J, et al. Expression analysis of serum microRNAs in idiopathic pulmonary fibrosis. Int J Mol Med. 2014;33:1554\u201362. https:\/\/doi.org\/10.3892\/ijmm.2014.1712.","journal-title":"Int J Mol Med"},{"key":"3392_CR39","doi-asserted-by":"publisher","first-page":"16420","DOI":"10.1074\/jbc.M117.805747","volume":"292","author":"C Huang","year":"2017","unstructured":"Huang C, Xiao X, Yang Y, Mishra A, Liang Y, Zeng X, et al. Microrna-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation. J Biol Chem. 2017;292:16420\u201339. https:\/\/doi.org\/10.1074\/jbc.M117.805747.","journal-title":"J Biol Chem"},{"key":"3392_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9523","volume":"6","author":"S Su","year":"2015","unstructured":"Su S, Zhao Q, He C, Huang D, Liu J, Chen F, et al. MiR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program. Nat Commun. 2015;6:8523. https:\/\/doi.org\/10.1038\/ncomms9523.","journal-title":"Nat Commun"},{"key":"3392_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.freeradbiomed.2013.05.022","volume":"64","author":"S Nallamshetty","year":"2013","unstructured":"Nallamshetty S, Chan SY, Loscalzo J. Hypoxia: a master regulator of MicroRNA biogenesis and activity. Free Radic Biol Med. 2013;64:20\u201330. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.05.022.","journal-title":"Free Radic Biol Med"},{"key":"3392_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ncrna.2024.11.004","volume":"11","author":"A Sufianov","year":"2024","unstructured":"Sufianov A, Agaverdiev M, Mashkin A, Ilyasova T. The functions of immune system-derived MiRNAs in cardiovascular diseases. Noncoding RNA Res. 2024;11:91\u2013103. https:\/\/doi.org\/10.1016\/j.ncrna.2024.11.004.","journal-title":"Noncoding RNA Res"},{"key":"3392_CR43","doi-asserted-by":"publisher","DOI":"10.2196\/42421","volume":"4","author":"M Khokhar","year":"2023","unstructured":"Khokhar M, Purohit P, Gadwal A, Tomo S, Bajpai NK, Shukla R. The differentially expressed genes responsible for the development of T helper 9 cells from T helper 2 cells in various disease states: immuno-interactomics study. JMIR Bioinform Biotechnol. 2023;4:e42421. https:\/\/doi.org\/10.2196\/42421.","journal-title":"JMIR Bioinform Biotechnol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03392-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:37:58Z","timestamp":1771324678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-025-03392-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3392"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03392-6","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with the Declaration of Helsinki and Good Clinical Practies, and approved by the Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital Ethics Committee (IIS-FJD CEIm: PIC010-21_FJD). All participants provided signed informed consent to be enrolled in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}